Safety, immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 year old children
Authors:
- Olga Castillo de FebresOFOlga Castillo de Febres
- Maria Chacon de PetrolaMPMaria Chacon de Petrola
- Laddy Casanova de EscalonaLELaddy Casanova de Escalona
- Oscar NavedaONOscar Naveda
- Miriam NavedaMNMiriam Naveda
- Milagros EstopinanMEMilagros Estopinan
- Glenda BordonesGBGlenda Bordones
- Betzana ZambranoBZBetzana Zambrano
- Albert GarciaAGAlbert Garcia
- Rafaele DumasRDRafaele Dumas
- 1 November 1999
- Vol. 18 (7-8) , 656-664
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Clinical development of a new inactivated hepatitis a vaccineInfection, 1996
- Analysis of the Antibody Response in Humans with a New Inactivated Hepatitis A VaccineBiologicals, 1996
- Response to Hepatitis A Vaccine in Children after a Single Dose with a Booster Administration 6 Months LaterJournal of Travel Medicine, 1996
- Immunogenicity and safety of a new inactivated hepatitis A vaccine: a clinical trial with comparison of administration routeVaccine, 1996
- Long‐term immunogenicity and safety of an inactivated hepatitis A vaccine in haemophilic patientsHaemophilia, 1996
- Safety and immunogenicity of an inactivated hepatitis A vaccine in children 2 to 5 years oldInfection, 1995
- Vaccination against Hepatitis A Virus in French Hemophilic ChildrenVox Sanguinis, 1995
- Persistence of vaccine-induced antibodies for hepatitis A virusVaccine, 1994
- Immunogenicity, safety and tolerability of varying doses and regimens of inactivated hepatitis A virus vaccine in Navajo childrenThe Pediatric Infectious Disease Journal, 1994
- Inactivated hepatitis A vaccine in childhood: implications for disease controlVaccine, 1993